Heron Therapeutics, Inc. (HRTX) stock
HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.00 (-0.74%)
Close on Nov 17, 2026Market cap $53.58MP/E –Yield –
Heron Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Heron Therapeutics's price to book ratio was 9.6× on Nov 11, 2026, against 13.1× a year earlier. Over the last 5 years it ranged from 2.6× to 21.0×, with a median of 6.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.6× | −5.1 |
| 2025 | Dec 31, 2025 | 14.7× | −6.3 |
| 2023 | Apr 28, 2023 | 21.0× | +15.0 |
| 2022 | Apr 29, 2022 | 5.9× | −1.4 |
| 2021 | Dec 31, 2021 | 7.4× | +0.5 |
| 2020 | Dec 31, 2020 | 6.9× | +0.4 |
| 2019 | Dec 31, 2019 | 6.5× | +2.2 |
| 2018 | Dec 31, 2018 | 4.3× | −18.0 |
| 2017 | Dec 29, 2017 | 22.3× | −4.8 |
| 2016 | Dec 30, 2016 | 27.2× | +21.3 |
| 2015 | Dec 31, 2015 | 5.9× | +2.9 |
| 2014 | Dec 31, 2014 | 3.0× | −3.6 |
| 2013 | Dec 31, 2013 | 6.6× | +1.2 |
| 2012 | Apr 30, 2012 | 5.3× | −5.6 |
| 2011 | Jul 29, 2011 | 11.0× | – |
See a number that looks wrong?